FDA Warning Letter — Ampride/Cenex

Case 622344 — FEI 3014609487

The FDA took a Warning Letter action against Ampride/Cenex on Dec 2, 2021 (Crookston, MN). The action was issued by CTP and concerns tobacco products.

Action details

Facility
Ampride/Cenex
Date
Dec 2, 2021
Fiscal Year
2022
Product Type
Tobacco
Center
CTP
Location
Crookston, MN (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.